According to Inter Group, on August 18, Inter Group and Hangzhou People's Insurance held a strategic cooperation signing ceremony to jointly launch the province's exclusive specialty drug commercial insurance — “Inte-Human Insurance 'Drug' Health Insurance.” “Pharmaceutical” health insurance focuses on the core needs of users, selects high-value varieties, and creates a commercial insurance solution that can be implemented. The first phase covered 45 varieties, involving more than 30 pharmaceutical companies including Hengrui, Novartis, and AstraZeneca, covering more than 10 high-incidence cancers such as lung cancer, breast cancer, and stomach cancer, as well as drugs for rare diseases such as neuromyelitis optica and neuroblastoma.
Zhitongcaijing · 1d ago
Share
Listen to the news
According to Inter Group, on August 18, Inter Group and Hangzhou People's Insurance held a strategic cooperation signing ceremony to jointly launch the province's exclusive specialty drug commercial insurance — “Inte-Human Insurance 'Drug' Health Insurance.” “Pharmaceutical” health insurance focuses on the core needs of users, selects high-value varieties, and creates a commercial insurance solution that can be implemented. The first phase covered 45 varieties, involving more than 30 pharmaceutical companies including Hengrui, Novartis, and AstraZeneca, covering more than 10 high-incidence cancers such as lung cancer, breast cancer, and stomach cancer, as well as drugs for rare diseases such as neuromyelitis optica and neuroblastoma.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending